Gustavo Borges

Gustavo Borges

Auto-generated profile, based on publicly available information

Gustavo Borges

Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Canada

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2020 in Blood
Verified
Journal Article
Closed access
PDF file
LCLuiz Fernando B. Catto
Luiz Fernando B. Catto
GBGustavo Borges
Gustavo Borges
APAndre Luiz Pinto
Andre Luiz Pinto
DCDiego V. Clé
Diego V. Clé
FCFernando Chahud
Fernando Chahud
RCRodrigo T. Calado
Rodrigo T. Calado
Haploinsufficiency of GATA2 caused by heterozygous loss-of-function mutations is associated with cytopenias and predisposition to myelodysplasia and AML with other variable extrahematopoietic manifestions, including lymphedema, pulmonary alveolar proteinosis, and hearing loss. The authors report on 2 siblings with the disorder whose father was asymptomatic because of an acquired missense mutation in the affected allele that was restricted to hematopoietic cells; surprisingly, he also had no extrahematopoietic complications.

6 November 2017 in Genetics and Molecular Biology
Verified
Journal Article
Open access
PDF file
CECláudia Carolina Silva Evangelista
Cláudia Carolina Silva Evangelista
GGGiovanna Vieira Guidelli
Giovanna Vieira Guidelli
GBGustavo Borges
Gustavo Borges
TAThais Fenz Araujo
Thais Fenz Araujo
TSTiago Alves Jorge de Souza
Tiago Alves Jorge de Souza
TPTiago Pereira
Tiago Pereira
The molecular basis of anhydrobiosis, the state of suspended animation entered by some species during extreme desiccation, is still poorly understood despite a number of transcriptome and proteome studies. We therefore conducted functional screening by RNA interference (RNAi) for genes involved in anhydrobiosis in the holo-anhydrobiotic nematode Panagrolaimus superbus. A new method of survival analysis, based on staining, and proof-of-principle RNAi experiments confirmed a role for genes involved in oxidative stress tolerance, while a novel medium-scale RNAi workflow identified a further 40 anhydrobiosis-associated genes, including several involved in proteostasis, DNA repair and signal transduction pathways. This suggests that multiple genes contribute to anhydrobiosis in P. superbus.

31 December 2013 in ISRN Parasitology
Verified
Journal Article
Open access
PDF file
TPTiago Pereira
Tiago Pereira
CECláudia Carolina Silva Evangelista
Cláudia Carolina Silva Evangelista
GBGustavo Borges
Gustavo Borges
EZEliana Maria Zanotti-Magalhães
Eliana Maria Zanotti-Magalhães
LMLuiz Augusto Magalhães
Luiz Augusto Magalhães
Iscia Lopes-CendesIscia Lopes-Cendes
Iscia Lopes-Cendes
The study of Schistosoma species has undergone a dramatic change in recent years mainly due to transcriptome, proteome, and genome analyses. In order to better understand the biology of the parasite and to develop new and more efficient/specific drugs, scientists have now the task to translate genetic information into functional data. The present paper aims to review the use of RNA interference (RNAi), a versatile technique used in gene silencing, for the dissection of the cellular/molecular biology of Schistosoma spp. In addition, we will review information on the recent development of a new generation of RNA-based drugs. Examples of specific experimental approaches will be presented and discussed, such as identification of gene function, development of therapies by targeting eggs, miracidia (as a strategy for environmental use), sporocysts (for infestation control in the intermediate host), and schistosomula/adult worms (as a treatment strategy). Furthermore, some of the main advantages, drawbacks, and future directions of these new applications and techniques will also be discussed.

29 April 2019 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
DMDaniela Palheiro Mendes-de-Almeida
Daniela Palheiro Mendes-de-Almeida
FAFrancianne Gomes Andrade
Francianne Gomes Andrade
GBGustavo Borges
Gustavo Borges
FSFilipe V. dos Santos-Bueno
Filipe V. dos Santos-Bueno
IVIracema F. Vieira
Iracema F. Vieira
MPMaria S. Pombo-De-Oliveira
Maria S. Pombo-De-Oliveira
GATA2 is a transcription factor that is a critical regulator of gene expression in hematopoietic cells. GATA2 deficiency presents with multi-lineage cytopenia, mycobacterial, fungal and viral infections. Patients with GATA2 mutation have a high risk of developing myelodysplastic syndrome or acute myeloid leukemia. We described a 43 years-old white male with 20-year follow-up of autoimmune and thrombotic phenomena, hypothyroidism, disseminated refractory Mycobacterium kansasii infection and MonoMAC syndrome. GATA2 c.1061 C > T; p.T354 M mutation was identified after he progressed from myelodysplastic pancytopenia to refractory anemia with excess blasts type II. His relatives were also investigated and he underwent unsuccessful haematopoietic stem cell transplantation. We discuss the clinical features, genetic diagnosis and treatment of this immunodeficiency disorder. This case illustrates the challenge how a multidisciplinary disease should be handle. Once usual causes of immunodeficiency were excluded, clinicians should considerGATA2 deficiency in patients with myelodysplasia and long-standing Mycobacterium kansasii infection.

14 April 2018 in Hematology, Transfusion and Cell Therapy
Verified
Journal Article
Open access
PDF file
PPPedro Henrique Padilha
Pedro Henrique Padilha
GBGustavo Borges
Gustavo Borges
BSBarbara Amélia Santana
Barbara Amélia Santana
LMLarissa Alessandra Medeiros
Larissa Alessandra Medeiros
SNSamir Kanaan Nabhan
Samir Kanaan Nabhan
RCRodrigo Tocantins Calado
Rodrigo Tocantins Calado
Background: Human aplastic anemia is a hematologic disease characterized by low peripheral blood cell counts associated with reduced numbers of hematopoietic stem and progenitor cells and a hypocellular bone marrow. Thrombopoietin (THPO) regulates megakaryocytes, but it also stimulates hematopoietic stem and progenitor cells. Biallelic mutations in the THPO gene have been reported in a family with recessive inherited aplastic anemia. Methods: This study screened 83 patients diagnosed with acquired aplastic anemia and 92 paired healthy controls for germline variants in the THPO gene using Sanger sequencing. Results: Three common single nucleotide polymorphisms were identified in patients and controls at comparable allele frequencies. There was no correlation between the single nucleotide polymorphism carrier status and platelet counts at diagnosis. Conclusion: The presence of THPO polymorphisms is comparable between patients with acquired aplastic anemia and healthy individuals.

6 October 2026 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Closed access
PDF file
BDBirinder Singh Doad
Birinder Singh Doad
GBGustavo Borges
Gustavo Borges
YZYusheng Zhao
Yusheng Zhao
DLDanny Laurent
Danny Laurent
SLSusan P. Lees-Miller
Susan P. Lees-Miller
ANAru Narendran
Aru Narendran